Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study.

Talip E Eroglu Ruben CoronelPatrick C Souverein

Published in: European heart journal. Cardiovascular pharmacotherapy (2024)

SGLT-2is were associated with a reduced risk of AF in patients with type 2 diabetes compared to other second-to third-line antidiabetic drugs. This reduced risk occurs in both sexes but more prominently among women.

Keyphrases

atrial fibrillation
polycystic ovary syndrome
oral anticoagulants
left atrial
catheter ablation
heart failure
left atrial appendage
direct oral anticoagulants
breast cancer risk
metabolic syndrome
insulin resistance
adipose tissue
coronary artery disease
left ventricular
acute coronary syndrome
drug induced